A retrospective study of six patients with late-onset Pompe disease;Forme adulte de la maladie de Pompe : à propos de six cas de la région du Languedoc-Roussillon

Revue Neurologique

Volumn 164, Issue 4, 2008, Pages 336-342

  Saux, A ^a   Laforet, P ^b   Pages A M ^c   Figarella Branger, D ^d   Pellissier, J F ^d   Pages M ^c   Labauge, P ^a  

^a DEPARTMENT OF NEUROLOGY   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

Glycogenosis; Maltase deficiency; Pompe disease

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSPNEA; ENZYME ANALYSIS; FATALITY; GAIT DISORDER; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; OUTCOME ASSESSMENT; RESPIRATORY FAILURE;

ADULT; AGE OF ONSET; ALPHA-GLUCOSIDASES; BIOPSY; DISEASE PROGRESSION; DYSPNEA; FEMALE; GAIT DISORDERS, NEUROLOGIC; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLES; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 46049095915     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2007.09.008     Document Type: Article

References (20)

1. Amalfitano A., Bengur A.R., Morse R.P., et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3 (2001) 132-138
2. Fernandez C., Maues de Paula A., Figarella-Branger D., et al. Diagnostic evaluation of clinically normal subjects with chronic hyper-Ckemia. Neurology 66 (2006) 1585-1587
3. Gelb M.H., Turecek F., Scott C.R., and Chamoles N.A. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 29 (2006) 397-404
4. Hagemans M.L., Hop W.J., Van Doorn P.A., Reuser A.J., and Van der Ploeg A.T. Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 66 (2006) 581-583
5. Hagemans M.L., Winkel L.P., Van Doorn P.A., Hop W.J., Loonen M.C., Reuser A.J., et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 128 (2005) 671-677
6. Hers H.G. Alpha-glucosidase deficiency in generalised glycogen-storage disease (Pompe's Disease). Biochem J 86 (1963) 11-16
7. Hoefsloot L.H., Hoogeveen-Westerveld M.M.P., Reuser A.J., and Oostra B.A. Characterization of the human lysosomal alpha-glucosidase gene. Biochem J 272 (1990) 493-497
8. Hudgson P., Gardner-Medwin D., Worsfold M., Pennington R.J., and Walton J.N. Adult myopathy from glycogen storage disease due to acid maltase deficiency. Brain 91 (1968) 435-462
9. Kishnani P.S., Corzo D., Nicolino M., et al. Recombinant human acid alpha-glucosidase. Major clinical benefits in infantile-onset Pompe disease. Neurology 68 (2007) 99-109
10. Klinge L., Straub V., Neudorf U., et al. Safety and efficacy of recombinant acid alpha-glucosidase in patient with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord 15 (2005) 24-31
11. Kroos M.A., Pomponio R.J., Hagemans M.L., et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T > G haplotype. Neurology 68 (2007) 110-115
12. Kroos M.A., Van der Kraan M., Van Diggelen O.P., et al. Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32 (1995) 836-837
13. Laforet P., Nicolino M., Eymard B., Puech J.P., Caillaud C., Poenaru L., et al. Juvenile and adult onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology 55 (2000) 1122-1128
14. Martiniuk F., Bodkin M., Tzall S., and Hirschhorn R. Isolation and partial characterization of the structural gene for human acid alpha glucosidase. DNA Cell Biol 10 (1991) 283-292
15. Mellies U., Stehling F., Dohna-Schwake C., Ragette R., Teschler H., and Voit T. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 64 (2005) 1465-1467
16. Pompe J.C. Over idiopathische hypertrophie van het hart. Ned Tijdschr Geneeskd 76 (1932) 304-312
17. Van den Hout H.M., Hop W., van Diggelen O.P., et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the litterature. Pediatrics 112 (2003) 332-340
18. Winkel L.P., Hagemans M.L., Van Doorn P.A., Loonen M.C., Hop W.J., Reuser A.J., et al. The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol 252 (2005) 875-884
19. Winkel L.P., Van der Hout J.M., Kamphoven J.H., et al. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Ann Neurol 55 (2004) 495-502
20. Wokke J.H., Ausems M.G., van den Boogaard M.J., Ippel E., et al. Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 3 (1995) 450-454